Published in Cancer Weekly, September 21st, 1998
Scientists have theorized that finasteride, sold under the brand name Proscar and commonly used to treat benign prostate disease, might offer men a way to cut their risk of developing prostate cancer.
Yet, "it appears that finasteride may not be effective as a chemopreventive agent against prostate cancer, at least in men with high PSA levels," according to Ronald K. Ross, MD, USC professor of preventive medicine and deputy director of the USC/Norris Cancer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.